Jump to navigation

  • IHME
  • GHDx
  • GBD Compare
Home
Main menu
  • Home
  • Results
    • GBD Results Tool
    • Data Visualizations
    • Country Profiles
    • GBD 2019 Cause and Risk Summaries
    • US Health
    • Policy Reports
    • Research Articles
    • Infographics
    • Topics
    • Data & Tools
  • News & Events
    • News
    • Commentaries
    • Events
    • Videos
    • Acting on Data
      • IHME Foundations
  • Projects
    • COVID-19 resources
    • Global Burden of Disease (GBD)
    • Center for Health Trends and Forecasts (CHTF)
    • Disease Control Priorities Network (DCPN)
    • View all
  • Get Involved
    • Donate
    • Careers
    • Call for Collaborators
    • The Roux Prize
    • Murray-Lopez Award
    • Online Training
    • Workshops
  • About
    • Our Principles
    • Racism is a public health issue.
    • Senior Management Team
    • Faculty
    • Governance
    • History
    • GHDx
    • Terms and Conditions
    • Contact Us

Explore section

News & Events

  • News
  • Commentaries
  • Events
  • Videos
  • Acting on Data
    • IHME Foundations

Nature Medicine: Universal US mask wearing could save nearly 130,000 lives by the end of February 2021


Twitter
Facebook
Google+
LinkedIn
Pinterest
Email
Print
Publication date: 
October 23, 2020

(NOTE: This press release and the study it references do not include the most current IHME forecasts for daily and cumulative deaths in the United States related to COVID-19. Those forecasts are available here.)

More than a half million lives could be lost to COVID-19 by 28 February 2021 in the USA, suggests a modeling study published in Nature Medicine. The paper also estimates that universal mask use could prevent the worst effects of epidemic resurgences in many states and could save nearly 130,000 of those half million lives.

There is still no approved vaccine against COVID-19 and there are few pharmaceutical options for the treatment of COVID-19 in the USA. Therefore, non-pharmaceutical interventions—such as the wearing of masks, social distancing, increased testing and the isolation of infected people—are the only tools available for reducing transmission. 

Christopher Murray and colleagues present a state-level epidemiological analysis of the spread of SARS-CoV-2 infection across the USA and the impact of non-pharmaceutical interventions, from the first recorded case to 21 September 2020. Using a ‘Susceptible, Exposed, Infectious, Recovered’ framework, the authors include projections of several variables—including seasonal pneumonia, mobility, testing rates and mask use per capita—to assess various scenarios of social-distancing mandates and levels of mask use from 22 September 2020 to 28 February 2021. Under all scenarios, the authors find that the USA is likely to face a continued COVID-19 public-health challenge through the winter, with populous states—such as California, Texas and Florida—in particular facing high levels of illness, deaths (as many as 511,373) and demands on hospital resources. 

However, new epidemics and resurgences are not inevitable, the authors suggest. Several countries have sustained reductions in COVID-19 over time. Mask use is a relatively affordable and low-impact intervention that can save lives across the USA. The authors estimate that universal mask use (if 95% of the population in each state always wore a mask when in public) could save an additional 129,574 lives through the end of February 2021, or an additional 95,814 lives under a scenario of less adoption of mask wearing. 

Contact: [email protected].

Related Content

Projects

COVID-19 resources
IHME’s COVID-19 projections were developed in response to requests from the University of Washington School of Medicine and other US hospital systems and state...

News & Events

  • News
  • Commentaries
  • Events
  • Videos
  • Acting on Data
    • IHME Foundations

Sign up for IHME News

Media contacts

[email protected]

Stay connected

     

IHME

Institute for Health Metrics and Evaluation

Population Health Building/Hans Rosling Center

3980 15th Ave. NE, Seattle, WA 98195

UW Campus Box #351615

Tel: +1-206-897-2800

Fax: +1-206-897-2899

© 2020 University of Washington

  • Privacy policy
  • Login

  • Home
  • Results
    • GBD Results Tool
    • Data Visualizations
    • Country Profiles
    • GBD 2019 Cause and Risk Summaries
    • US Health
    • Policy Reports
    • Research Articles
    • Infographics
    • Topics
    • Data & Tools
  • News & Events
    • News
    • Commentaries
    • Events
    • Videos
    • Acting on Data
  • Projects
    • COVID-19 resources
    • Global Burden of Disease (GBD)
    • Center for Health Trends and Forecasts (CHTF)
    • Disease Control Priorities Network (DCPN)
    • View all
  • Get Involved
    • Donate
    • Careers
    • Call for Collaborators
    • The Roux Prize
    • Murray-Lopez Award
    • Online Training
    • Workshops
  • About
    • Our Principles
    • Racism is a public health issue.
    • Senior Management Team
    • Faculty
    • Governance
    • History
    • GHDx
    • Terms and Conditions
    • Contact Us

Projects

  • Global Burden of Disease (GBD)
  • Disease Control Priorities Network (DCPN)
  • ABCE+: A Focus on Antiretroviral Therapy (ART)
  • Access, Bottlenecks, Costs, and Equity (ABCE)
  • Efficacy to Effectiveness
  • Viral Load Pilot
  • Salud Mesoamérica Initiative
  • Improving Methods to Measure Comparable Mortality by Cause
  • Verbal Autopsy (VA)
  • Disease Expenditure (DEX)
  • Local Burden of Disease
  • State-level disease burden initiative in India
  • US Counties Drivers of Health Study
  • University of Washington Center for Health Trends and Forecasts